Search Results - "Kwek, Serena S"
-
1
Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus
Published in Science (American Association for the Advancement of Science) (08-04-2022)“…Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Knowledge of circulating immune cell types and states associated with SLE remains…”
Get full text
Journal Article -
2
Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire
Published in Cancer research (Chicago, Ill.) (15-03-2017)“…While immune checkpoint blockade elicits efficacious responses in many patients with cancer, it also produces a diverse and unpredictable number of…”
Get full text
Journal Article -
3
GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses
Published in Oncoimmunology (02-04-2016)“…We conducted a phase II clinical trial of anti-CTLA-4 antibody (ipilimumab) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in 22 patients with…”
Get full text
Journal Article -
4
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
Published in Cell (25-06-2020)“…Responses to anti-PD-1 immunotherapy occur but are infrequent in bladder cancer. The specific T cells that mediate tumor rejection are unknown. T cells from…”
Get full text
Journal Article -
5
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Published in Cell (26-01-2017)“…Immune responses involve coordination across cell types and tissues. However, studies in cancer immunotherapy have focused heavily on local immune responses in…”
Get full text
Journal Article -
6
Unmasking the immune recognition of prostate cancer with CTLA4 blockade
Published in Nature reviews. Cancer (01-04-2012)“…Cytotoxic T lymphocyte-associated antigen 4 (CTLA4) represents a crucial immune checkpoint, the blockade of which can potentiate anti-tumour immunity. This…”
Get full text
Journal Article -
7
Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function
Published in Nature immunology (01-04-2023)“…Gamma delta (γδ) T cells reside within human tissues including tumors, but their function in mediating antitumor responses to immune checkpoint inhibition is…”
Get full text
Journal Article -
8
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
Published in Immunity (Cambridge, Mass.) (19-02-2019)“…Resistance to checkpoint-blockade treatments is a challenge in the clinic. We found that although treatment with combined anti-CTLA-4 and anti-PD-1 improved…”
Get full text
Journal Article -
9
Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients
Published in The Journal of immunology (1950) (01-10-2012)“…CTLA-4 is a surface receptor on activated T cells that delivers an inhibitory signal, serving as an immune checkpoint. Treatment with anti-CTLA-4 Abs can…”
Get full text
Journal Article -
10
Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF
Published in Cancer research (Chicago, Ill.) (15-01-2009)“…CTL-associated antigen 4 (CTLA4) is a costimulatory molecule expressed on activated T cells that delivers an inhibitory signal to these T cells. CTLA4 blockade…”
Get full text
Journal Article -
11
Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma
Published in Cancer Immunology, Immunotherapy (01-10-2021)“…Background Soft-tissue sarcomas (STS) are a rare group of mesenchymal malignancies that account for approximately 1% of adult human cancer. Undifferentiated…”
Get full text
Journal Article -
12
Functional analysis and intracellular localization of p53 modified by SUMO-1
Published in Oncogene (03-05-2001)“…p53 tumor suppressor is a subject of several post-translational modifications, including phosphorylation, ubiquitination and acetylation, which regulate p53…”
Get full text
Journal Article -
13
Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab
Published in Cancer immunology research (01-09-2015)“…Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blockade can induce tumor regression and improved survival in cancer patients. This treatment can enhance…”
Get more information
Journal Article -
14
Apoptosis Inhibitor as a Suppressor of Tumor Progression: Expression of Bcl-2 Eliminates Selective Advantages for p53-Deficient Cells in the Tumor
Published in Cancer biology & therapy (01-01-2002)“…Inactivation of p53 and expression of Bcl-2, frequently occurring during tumor progression, have different prognostic value: while inactivation of p53 is…”
Get full text
Journal Article -
15
Abstract 4688: Single-cell discrimination of altered human T cell states in the bladder tumor microenvironment
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Bladder cancer can be responsive to immunotherapies such as anti-PD-1 and anti-PD-L1 checkpoint inhibitors, but overall response rates are low…”
Get full text
Journal Article -
16
Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis
Published in Oncogene (30-04-2009)“…Co-amplification at chromosomes 8p11–8p12 and 11q12–11q14 occurs often in breast tumors, suggesting possible cooperation between genes in these regions in…”
Get full text
Journal Article -
17
Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence
Published in Oncogene (18-12-1997)“…Mutations in the p53 tumor suppressor gene are frequently associated with the metastatic stage of tumor progression. Inactivation of p53 was shown to promote…”
Get full text
Journal Article -
18
Structure and Regulation of the Mouse ing1 Gene
Published in The Journal of biological chemistry (05-11-1999)“…The human ING1 gene encodes nuclear protein p33ING1, previously shown to cooperate with p53 in cell growth control (Garkavtsev, I., Grigorian, I. A.,…”
Get full text
Journal Article